Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 1
2008 7
2009 2
2010 2
2011 5
2012 6
2013 7
2014 5
2015 3
2016 2
2017 5
2018 2
2019 4
2020 3
2021 10
2022 8
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Assessment of osteoporotic fractures and risk prediction.
Cheng X, Sheng ZF, Wang X. Cheng X, et al. Front Endocrinol (Lausanne). 2022 Dec 19;13:1107678. doi: 10.3389/fendo.2022.1107678. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36601004 Free PMC article. No abstract available.
Consensus on clinical management of tumor-induced osteomalacia.
Jiang Y, Li X, Huo L, Liu Y, Lyu W, Zhou L, Yu W, Wu HW, Xing XP, Li M, Wang O, Chi Y, Jiajue RZ, Pei Y, Liu JM, Ba JM, Zhang Q, Sheng ZF, Zhang ZL, Zhao JJ, Minisola S, Xia WB; Chinese Society of Osteoporosis and Bone Mineral Research and Chinese Society of Endocrinology. Jiang Y, et al. Chin Med J (Engl). 2021 Apr 1;134(11):1264-1266. doi: 10.1097/CM9.0000000000001448. Chin Med J (Engl). 2021. PMID: 33813513 Free PMC article. No abstract available.
Low-Level Cadmium Exposure and Bone Health.
Xie D, Sheng Z. Xie D, et al. Among authors: sheng z. J Bone Miner Res. 2017 Feb;32(2):419. doi: 10.1002/jbmr.3049. Epub 2017 Jan 10. J Bone Miner Res. 2017. PMID: 27925278 Free article. No abstract available.
Multiple doses of SHR-1222, a sclerostin monoclonal antibody, in postmenopausal women with osteoporosis: A randomized, double-blind, placebo-controlled, dose-escalation phase 1 trial.
Dai Z, Zhu R, Sheng Z, Qin G, Luo X, Qin Q, Song C, Li L, Jin P, Yang G, Cheng Y, Peng D, Zou C, Wang L, Shentu J, Zhang Q, Zhang Z, Yan X, Fang P, Yan Q, Yang L, Fan X, Liu W, Wu B, Cui R, Wu X, Xie Y, Shu C, Shen K, Wei W, Lu W, Chen H, Zhou Z. Dai Z, et al. Among authors: sheng z. Front Endocrinol (Lausanne). 2023 Apr 5;14:1168757. doi: 10.3389/fendo.2023.1168757. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37091850 Free PMC article. Clinical Trial.
77 results